Pre-Operative Sterilization Study of Levofloxacin Ophthalmic Solution 1.5%

Pre-Operative Sterilization Study of Levofloxacin Ophthalmic Solution 1.5% - Pre-Operative Sterilization Study of Levofloxacin Ophthalmic Solution

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007622

Enrollment

Registered

2012-04-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases necessary for intraocular Surgery

Interventions

Administration of antibacterial ophthalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Fifteen and under children and 20 and upper adults 2.Patients scheduled for intraocular surgery

Exclusion criteria

Exclusion criteria: 1.Patients with history of hypersensitivity or severe adverse effects on newquinolone antibiotics 2.Patients suspecting bacterium, fungus or virus infection 3.Patients administered antibiotics or immunosuppressants within 3 months prior to the study 4.Patients hospitalized other than ocular surgeries 5.Patients with uncontrollable underlying disorders or complications 6.Pregnant or breast-feeding women 7.Patients wearing contact lenses during the study 8.Patients having history of ocular surgery within 3 months prior to the study on the study eye 9. Patients whom investigators estimate are not eligible

Design outcomes

Primary

Measure	Time frame
Pre-Operative bacterial eradication rate of Levofloxacin Ophthalmic Solution 1.5%	—

Countries

Japan

Contacts

Public ContactYukiko Terada

Miyata eye Hospital Miyata eye Hospital

yukkkkkk@gk9.so-net.ne.jp0986-22-1441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026